This supplement will review the technology, data and clinical experiences using the MyoSure® Hysteroscopic Tissue Removal System (Myosure Tissue Removal System).
Revolutionizing Hysteroscopic Tissue Removal Using the MyoSure® System
Abnormal uterine bleeding affects approximately 30% of women. Ultimately, direct visualization via hysteroscopy is known to provide a minimally invasive approach to visualize the endometrial cavity and enable subsequent removal of structural uterine lesions using electrosurgical loop or hysteroscopic morcellation. This supplement will review the technology, data and clinical experiences using the MyoSure® Hysteroscopic Tissue Removal System (Myosure Tissue Removal System).
Diabetes linked to altered long-term inflammatory response in mesh implantation
July 15th 2024A recent study highlights the association between diabetes and complications from urogynecologic mesh implants, emphasizing the need for further research on glycemic control in affected patients.
Read More